| 000 | 01771 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512035116.0 | ||
| 264 | 0 | _c19880315 | |
| 008 | 198803s 0 0 eng d | ||
| 022 | _a0272-6386 | ||
| 024 | 7 |
_a10.1016/s0272-6386(88)80189-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCantarovich, D | |
| 245 | 0 | 0 |
_aProphylactic use of a monoclonal antibody (33B3.1) directed against interleukin 2 receptor following human renal transplantation. _h[electronic resource] |
| 260 |
_bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _cFeb 1988 |
||
| 300 |
_a101-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aCadaver |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 |
_aGraft Rejection _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xanalysis |
| 650 | 0 | 4 |
_aImmunoglobulin M _xanalysis |
| 650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
| 650 | 0 | 4 |
_aInterleukin-2 _ximmunology |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _ximmunology |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Immunologic _ximmunology |
| 650 | 0 | 4 | _aReceptors, Interleukin-2 |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLe Mauff, B | |
| 700 | 1 | _aHourmant, M | |
| 700 | 1 | _aPeyronnet, P | |
| 700 | 1 | _aJacques, Y | |
| 700 | 1 | _aBoeffard, F | |
| 700 | 1 | _aHirn, M | |
| 700 | 1 | _aSoulillou, J P | |
| 773 | 0 |
_tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation _gvol. 11 _gno. 2 _gp. 101-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0272-6386(88)80189-6 _zAvailable from publisher's website |
| 999 |
_c3130406 _d3130406 |
||